LEO Pharma Inc. (Canada) Finalizes Letter of Intent with pCPA for Anzupgo® (delgocitinib cream) for Chronic Hand Eczema

BALLERUP, Denmark — ANZUPGO (delgocitinib cream) has taken a major step towards public reimbursement in Canada following the successful conclusion of negotiations between pan-Canadian Pharmaceutical Alliance (pCPA) and LEO Pharma Canada. This marks important progress toward access for adults with moderate to severe chronic hand eczema (CHE) whose disease is inadequately controlled with, or for […]